• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用机器学习算法预测晚期卵巢癌初次肿瘤细胞减灭术的结果。

Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer.

作者信息

Piedimonte Sabrina, Erdman Lauren, So Delvin, Bernardini Marcus Q, Ferguson Sarah E, Laframboise Stephane, Bouchard Fortier Genevieve, Cybulska Paulina, May Taymaa, Hogen Liat

机构信息

Gynecologic Oncology, University of Toronto, Toronto, Ontario, Canada.

Computer Science, The Hospital for Sick Children, Toronto, Ontario, Canada.

出版信息

J Surg Oncol. 2023 Mar;127(3):465-472. doi: 10.1002/jso.27137. Epub 2022 Nov 9.

DOI:10.1002/jso.27137
PMID:36350138
Abstract

OBJECTIVE

To develop a machine learning (ML) algorithm to predict outcome of primary cytoreductive surgery (PCS) in patients with advanced ovarian cancer (AOC) METHODS: This retrospective cohort study included patients with AOC undergoing PCS between January 2017 and February 2021. Using radiologic criteria, patient factors (age, CA-125, performance status, BRCA) and surgical complexity scores, we trained a random forest model to predict the dichotomous outcome of optimal cytoreduction (<1 cm) and no gross residual (RD = 0 mm) using JMP-Pro 15 (SAS). This model is available at https://ipm-ml.ccm.sickkids.ca.

RESULTS

One hundred and fifty-one patients underwent PCS and randomly assigned to train (n = 92), validate (n = 30), or test (n = 29) the model. The median age was 58 (27-83). Patients with suboptimal cytoreduction were more likely to have an Eastern Cooperative Oncology Group 3-4 (11% vs. 0.75%, p = 0.004), lower albumin (38 vs. 41, p = 0.02), and higher CA125 (1126 vs. 388, p = 0.012) than patients with optimal cytoreduction (n = 133). There were no significant differences in age, histology, stage, or BRCA status between groups. The bootstrap random forest model had AUCs of 99.8% (training), 89.6%(validation), and 89.0% (test). The top five contributors were CA125, albumin, diaphragmatic disease, age, and ascites. For RD = 0 mm, the AUCs were 94.4%, 52%, and 84%, respectively.

CONCLUSION

Our ML algorithm demonstrated high accuracy in predicting optimal cytoreduction in patients with AOC selected for PCS and may assist decision-making.

摘要

目的

开发一种机器学习(ML)算法,以预测晚期卵巢癌(AOC)患者的初次肿瘤细胞减灭术(PCS)结果。方法:这项回顾性队列研究纳入了2017年1月至2021年2月期间接受PCS的AOC患者。利用放射学标准、患者因素(年龄、CA-125、体能状态、BRCA)和手术复杂程度评分,我们使用JMP-Pro 15(SAS)软件训练了一个随机森林模型,以预测最佳肿瘤细胞减灭术(<1厘米)和无肉眼残留(RD = 0毫米)的二分结果。该模型可在https://ipm-ml.ccm.sickkids.ca获取。

结果

151例患者接受了PCS,并被随机分配用于训练(n = 92)、验证(n = 30)或测试(n = 29)该模型。中位年龄为58岁(27 - 83岁)。与实现最佳肿瘤细胞减灭术的患者(n = 133)相比,肿瘤细胞减灭术未达最佳的患者更有可能具有东部肿瘤协作组3 - 4级(11%对0.75%,p = 0.004)、白蛋白水平较低(38对41,p = 0.02)以及CA125水平较高(1126对388,p = 0.012)。两组在年龄、组织学、分期或BRCA状态方面无显著差异。自助随机森林模型在训练集、验证集和测试集上的曲线下面积(AUC)分别为99.8%、89.6%和89.0%。贡献最大的五个因素是CA125、白蛋白、膈肌疾病、年龄和腹水。对于RD = 0毫米,AUC分别为94.4%、52%和84%。

结论

我们的ML算法在预测接受PCS的AOC患者的最佳肿瘤细胞减灭术方面显示出高准确性,并可能有助于决策。

相似文献

1
Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer.使用机器学习算法预测晚期卵巢癌初次肿瘤细胞减灭术的结果。
J Surg Oncol. 2023 Mar;127(3):465-472. doi: 10.1002/jso.27137. Epub 2022 Nov 9.
2
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancer.高级卵巢癌肿瘤细胞减灭术结局的综合预测模型算法的验证。
Int J Gynecol Cancer. 2023 Jul 3;33(7):1077-1082. doi: 10.1136/ijgc-2022-004202.
3
Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer.综合预测模型的患者因素、可切除性评分和手术复杂性,以预测晚期卵巢癌的细胞减灭术效果并指导治疗计划。
Gynecol Oncol. 2022 Sep;166(3):453-459. doi: 10.1016/j.ygyno.2022.06.026. Epub 2022 Jul 9.
4
Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study.术前血清 HE4 和 CA125 水平预测晚期上皮性卵巢癌初次理想肿瘤细胞减灭术:初步模型研究。
J Ovarian Res. 2020 Feb 12;13(1):17. doi: 10.1186/s13048-020-0614-1.
5
CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer.CA125水平对晚期上皮性卵巢癌患者进行最佳肿瘤细胞减灭术的预测价值较弱。
Int J Gynecol Cancer. 2003 Mar-Apr;13(2):120-4. doi: 10.1046/j.1525-1438.2003.13019.x.
6
Minilaparotomy, Cyfra21-1, and Other Predicting Factors for Suboptimal Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer: A Pilot Study.经皮微波消融治疗晚期肝癌的疗效及安全性:一项荟萃分析
Asian Pac J Cancer Prev. 2022 Dec 1;23(12):4119-4124. doi: 10.31557/APJCP.2022.23.12.4119.
7
Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.上皮性卵巢癌女性新辅助化疗与原发性肿瘤细胞减灭术的总生存期:美国国立癌症数据库分析
JAMA Oncol. 2017 Jan 1;3(1):76-82. doi: 10.1001/jamaoncol.2016.4411.
8
Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.使用 HE4 对上皮性卵巢癌进行间隔细胞减灭术后残余疾病的术前预测。
Int J Gynecol Cancer. 2019 Oct;29(8):1304-1310. doi: 10.1136/ijgc-2019-000581. Epub 2019 Sep 11.
9
Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer.术前血清CA125水平不能预测上皮性卵巢癌的减瘤手术效果欠佳。
Int J Gynecol Cancer. 2008 Jul-Aug;18(4):621-8. doi: 10.1111/j.1525-1438.2007.01064.x. Epub 2007 Sep 14.
10
Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.晚期上皮性卵巢癌肿瘤减灭术中肠手术和造口形成后的临床特征和结局。
Int J Gynecol Cancer. 2019 Mar;29(3):585-592. doi: 10.1136/ijgc-2018-000154.

引用本文的文献

1
Artificial Intelligence in Gynecological Oncology from Diagnosis to Surgery.从诊断到手术的妇科肿瘤学中的人工智能
Cancers (Basel). 2025 Mar 21;17(7):1060. doi: 10.3390/cancers17071060.
2
Explainable AI-based feature importance analysis for ovarian cancer classification with ensemble methods.基于可解释人工智能的特征重要性分析在卵巢癌分类集成方法中的应用
Front Public Health. 2025 Mar 26;13:1479095. doi: 10.3389/fpubh.2025.1479095. eCollection 2025.
3
Predicting Response to Treatment and Survival in Advanced Ovarian Cancer Using Machine Learning and Radiomics: A Systematic Review.
使用机器学习和放射组学预测晚期卵巢癌的治疗反应和生存:一项系统综述。
Cancers (Basel). 2025 Jan 21;17(3):336. doi: 10.3390/cancers17030336.
4
Diagnostic accuracy of artificial intelligence algorithms to predict remove all macroscopic disease and survival rate after complete surgical cytoreduction in patients with ovarian cancer: a systematic review and meta-analysis.人工智能算法预测卵巢癌患者完全手术细胞减灭术后切除所有宏观病灶及生存率的诊断准确性:一项系统评价和荟萃分析。
BMC Surg. 2025 Jan 16;25(1):27. doi: 10.1186/s12893-025-02766-3.
5
Predicting the Recurrence of Ovarian Cancer Based on Machine Learning.基于机器学习预测卵巢癌复发
Cancer Manag Res. 2024 Oct 9;16:1375-1387. doi: 10.2147/CMAR.S482837. eCollection 2024.
6
Heterogeneity and treatment landscape of ovarian carcinoma.卵巢癌的异质性和治疗现状。
Nat Rev Clin Oncol. 2023 Dec;20(12):820-842. doi: 10.1038/s41571-023-00819-1. Epub 2023 Oct 2.
7
Prognostic Significance of Preoperative NLR, MLR, and PLR Values in Predicting the Outcome of Primary Cytoreductive Surgery in Serous Epithelial Ovarian Cancer.术前中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)及血小板与淋巴细胞比值(PLR)对预测浆液性上皮性卵巢癌初次肿瘤细胞减灭术预后的意义
Diagnostics (Basel). 2023 Jul 4;13(13):2268. doi: 10.3390/diagnostics13132268.